Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

63%

5 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

3(50.0%)

Phase 4

2(33.3%)

N/A

1(16.7%)

6Total

Phase 3(3)

Phase 4(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03796156Phase 3Terminated

Aspirin to Target Arterial Events in Chronic Kidney Disease

Role: collaborator

NCT03265574Phase 3Completed

PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?

Role: collaborator

NCT01506986Phase 4Completed

Helicobacter Eradication Aspirin Trial

Role: collaborator

NCT03576313Phase 3Completed

Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination

Role: collaborator

NCT00169117Not ApplicableCompleted

A Stitch in Time May Save Lives: Turning Poor Bednets Into Good Ones

Role: collaborator

NCT02009215Phase 4Completed

School-Based Treatment With ACT to Reduce Transmission

Role: collaborator

NCT01013883Completed

The Darlington Retrospective Outpatient Study

Role: collaborator

NCT01603927Unknown

Detect InSpect ChAracterise Resect and Discard 2

Role: collaborator

All 8 trials loaded